Fundamental Analysis
28 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -62.4% | -90.1% | 0 / 3 | +28.3% | -3.11 pp | -1.98 pp | +14.3% | 1.02 | 3.96 | 1.086 | +28,3% | 8,9 | −62,4% | 3.96 | 3.98 | −0,4% |
| Pts | 0 | 0 | 0 | 12 | 0 | 4 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 10.000 (close price on 2026-10-19)EPS (TTM): 2.523
Financial charts
1.Revenue & growth
VND bn1.086Q2/26
1.Revenue & growth
VND bn1.086Q2/26
2.Profit & growth
VND bn9,03Q2/26
3.Profit mix (Penman)
VND bn80,6Q2/26
4.Margins & cost structure
%9.1%Q2/26
5.Returns & cash cycle
% · days6.9%Q2/26
6.Earnings quality & cash
VND bn73,6Q2/26
7.Asset structure
VND bn1.473Q2/26
8.Funding & debt health
VND bn · times1.473Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %4,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %355Q2/26
Adjusted EPS growth, latest quarter
-61.9%
Average adjusted EPS growth, 3 quarters
-89.9%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26